Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Charles Craddock’s ASH 2019 transplant highlights

Charles Craddock • 10 Dec 2019
ASH 2019
Cyclophosphamide Cyclosporine Methotrexate

Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, University of Birmingham, Birmingham, UK, highlights the key updates in the transplantation field from the at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Prof. Craddock specifically discusses the use of GvHD prophylaxis, the challenge of maximizing safety and how the risk of relapse can be reduced.

More from Charles Craddock

2:14
Addressing the high rate of disease relapse following alloSCT in patients with AML
Charles Craddock • 10 Dec 2023
1:32
Stem cell transplantation conditioning in AML: making the decision between MAC and RIC
Charles Craddock • 10 Dec 2023
1:22
The UK Impact Transplant Trials Network: a national strategy to accelerate delivery of alloSCT RCTs
Charles Craddock • 10 Dec 2023
Transplantation & immunotherapies
Charles Craddock et al. • 4 Sep 2023
The content of VJHemOnc is intended for healthcare professionals